Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

Clinical trial NCT06678724 · RECRUITING

Trial details

NCT number: NCT06678724
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Head and Neck Cancers- Squamous Cell Head and Neck Cancer Metastatic Recurrent Head and Neck Squamous Cell Carcinoma

Start date: 2025-01-01
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.